中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 6
Jun.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2023  >  39(6): 1440-1445

Role of intrahepatic microenvironment induced-autophagy in nonalcoholic fatty liver disease

DOI: 10.3969/j.issn.1001-5256.2023.06.029

  • Institute of Pathology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China

Research funding:

National Natural Science Foundation of China (81670776);

National Natural Science Foundation of China (81970734)

More Information
  • Corresponding author: ZHANG Jiangang, zhjg@lzu.edu.cn (ORCID: 0000-0002-4143-9461)
  • Received Date: 2022-09-30
  • Accepted Date: 2022-11-28
  • Published Date: 2023-06-20
    Abstract
  • Nonalcoholic fatty liver disease (NAFLD) is a series of abnormal liver lesions mainly characterized by excessive lipid deposition in hepatocytes, and it is also the most common chronic liver disease worldwide. Autophagy is a basic cellular process in which cells degrade their own components and participate in the maintenance of organ function and body homeostasis, and it is closely associated with the progression of NAFLD. High fat, hypoxia, and stress in human body may cause abnormal changes in extracellular microenvironment in the liver, and such abnormal microenvironment may promote the development and progression of NAFLD by inducing liver cell autophagy. This article reviews the role and mechanism of autophagy of liver cells such as hepatocytes, Kupffer cells, and hepatic stellate cells in the progression of NAFLD based on various microenvironment characteristics in the liver.

     

    • FullText(HTML)
  • loading
    • References(49)
  • [1]
    RAVIKUMAR B, SARKAR S, DAVIES JE, et al. Regulation of mammalian autophagy in physiology and pathophysiology[J]. Physiol Rev, 2010, 90(4): 1383-1435. DOI: 10.1152/physrev.00030.2009.
    [2]
    FILALI-MOUNCEF Y, HUNTER C, ROCCIO F, et al. The ménage à trois of autophagy, lipid droplets and liver disease [J]. Autophagy, 2022, 18(1): 50-72. DOI: 10.1080/15548627.2021.1895658.
    [3]
    WANG L, KLIONSKY DJ, SHEN HM. The emerging mechanisms and functions of microautophagy[J]. Nat Rev Mol Cell Biol, 2023, 24(3): 186-203. DOI: 10.1038/s41580-022-00529-z.
    [4]
    KIRKIN V, ROGOV VV. A diversity of selective autophagy receptors determines the specificity of the autophagy pathway[J]. Mol Cell, 2019, 76(2): 268-285. DOI: 10.1016/j.molcel.2019.09.005.
    [5]
    TONG M, SAITO T, ZHAI P, et al. Mitophagy is essential for maintaining cardiac function during high fat diet-induced diabetic cardiomyopathy[J]. Circ Res, 2019, 124(9): 1360-1371. DOI: 10.1161/CIRCRESAHA.118.314607.
    [6]
    FENG X, ZHANG H, MENG L, et al. Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5[J]. Autophagy, 2021, 17(3): 723-742. DOI: 10.1080/15548627.2020.1731266.
    [7]
    CZAJA MJ, DING WX, DONOHUE TM Jr, et al. Functions of autophagy in normal and diseased liver[J]. Autophagy, 2013, 9(8): 1131-1158. DOI: 10.4161/auto.25063.
    [8]
    SOUZA MR, DINIZ MDE F, MEDEIROS-FILHO JE, et al. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease[J]. Arq Gastroenterol, 2012, 49(1): 89-96. DOI: 10.1590/s0004-28032012000100015.
    [9]
    OTA H, FUJITA Y, YAMAUCHI M, et al. Relationship between intermittent hypoxia and type 2 diabetes in sleep apnea syndrome[J]. Int J Mol Sci, 2019, 20(19): 4756. DOI: 10.3390/ijms20194756.
    [10]
    MILIĆ S, LULIĆ D, ŠTIMAC D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations[J]. World J Gastroenterol, 2014, 20(28): 9330-9337. DOI: 10.3748/wjg.v20.i28.9330.
    [11]
    LIAN CY, ZHAI ZZ, LI ZF, et al. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms[J]. Chem Biol Interact, 2020, 330: 109199. DOI: 10.1016/j.cbi.2020.109199.
    [12]
    RODRIGUES SG, MONTANI M, GUIXÉ-MUNTET S, et al. Patients with signs of advanced liver disease and clinically significant portal hypertension do not necessarily have cirrhosis[J]. Clin Gastroenterol Hepatol, 2019, 17(10): 2101-2109. e1. DOI: 10.1016/j.cgh.2018.12.038.
    [13]
    MENDES FD, SUZUKI A, SANDERSON SO, et al. Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol, 2012, 10(9): 1028-1033. e2. DOI: 10.1016/j.cgh.2012.05.008.
    [14]
    LONG Y, NIU Y, LIANG K, et al. Mechanical communication in fibrosis progression[J]. Trends Cell Biol, 2022, 32(1): 70-90. DOI: 10.1016/j.tcb.2021.10.002.
    [15]
    FU Y, ZHANG N, TANG W, et al. Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity[J]. Hepatol Int, 2022, 16(4): 824-834. DOI: 10.1007/s12072-022-10347-2.
    [16]
    VIGLINO D, JULLIAN-DESAYES I, MINOVES M, et al. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease[J]. Eur Respir J, 2017, 49(6): 1601923. DOI: 10.1183/13993003.01923-2016.
    [17]
    PIGUET AC, STROKA D, ZIMMERMANN A, et al. Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN[J]. Clin Sci (Lond), 2009, 118(6): 401-410. DOI: 10.1042/CS20090313.
    [18]
    SINGH R, KAUSHIK S, WANG Y, et al. Autophagy regulates lipid metabolism[J]. Nature, 2009, 458(7242): 1131-1135. DOI: 10.1038/nature07976.
    [19]
    DONG S, JIA C, ZHANG S, et al. The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy[J]. Cell Metab, 2013, 18(3): 380-391. DOI: 10.1016/j.cmet.2013.08.012.
    [20]
    LIU K, ZHAO E, ILYAS G, et al. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization[J]. Autophagy, 2015, 11(2): 271-284. DOI: 10.1080/15548627.2015.1009787.
    [21]
    MOORE MP, CUNNINGHAM RP, MEERS GM, et al. Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD[J]. Hepatology, 2022, 76(5): 1452-1465. DOI: 10.1002/hep.32324.
    [22]
    YAMADA T, MURATA D, ADACHI Y, et al. Mitochondrial stasis reveals p62-mediated ubiquitination in parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease[J]. Cell Metab, 2018, 28(4): 588-604. e5. DOI: 10.1016/j.cmet.2018.06.014.
    [23]
    LI R, XIN T, LI D, et al. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy[J]. Redox Biol, 2018, 18: 229-243. DOI: 10.1016/j.redox.2018.07.011.
    [24]
    ZHOU T, CHANG L, LUO Y, et al. Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy[J]. Redox Biol, 2019, 21: 101120. DOI: 10.1016/j.redox.2019.101120.
    [25]
    MEDERACKE I, HSU CC, TROEGER JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology[J]. Nat Commun, 2013, 4: 2823. DOI: 10.1038/ncomms3823.
    [26]
    BLANER WS, O'BYRNE SM, WONGSIRIROJ N, et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage[J]. Biochim Biophys Acta, 2009, 1791(6): 467-473. DOI: 10.1016/j.bbalip.2008.11.001.
    [27]
    HONG Y, LI S, WANG J, et al. In vitro inhibition of hepatic stellate cell activation by the autophagy-related lipid droplet protein ATG2A[J]. Sci Rep, 2018, 8(1): 9232. DOI: 10.1038/s41598-018-27686-6.
    [28]
    THOEN LF, GUIMARÃES EL, DOLLÉ L, et al. A role for autophagy during hepatic stellate cell activation[J]. J Hepatol, 2011, 55(6): 1353-1360. DOI: 10.1016/j.jhep.2011.07.010.
    [29]
    KIM JS, NITTA T, MOHUCZY D, et al. Impaired autophagy: A mechanism of mitochondrial dysfunction in anoxic rat hepatocytes[J]. Hepatology, 2008, 47(5): 1725-1736. DOI: 10.1002/hep.22187.
    [30]
    WANG D, SI D, LI G, et al. Dysregulated autophagic activity induced in response to chronic intermittent hypoxia contributes to the pathogenesis of NAFLD[J]. Front Physiol, 2022, 13: 941706. DOI: 10.3389/fphys.2022.941706.
    [31]
    LU Y, BIAN J, KAN H, et al. Intermittent hypoxia preconditioning protects WRL68 cells against oxidative injury: Involvement of the PINK1/Parkin-mediated mitophagy regulated by nuclear respiratory factor 1[J]. Mitochondrion, 2021, 59: 113-122. DOI: 10.1016/j.mito.2021.04.012.
    [32]
    CUI F, HU HF, GUO J, et al. The effect of autophagy on chronic intermittent hypobaric hypoxia ameliorating liver damage in metabolic syndrome rats[J]. Front Physiol, 2020, 11: 13. DOI: 10.3389/fphys.2020.00013.
    [33]
    ZHAN L, HUANG C, MENG XM, et al. Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target[J]. Biochimie, 2015, 108: 1-7. DOI: 10.1016/j.biochi.2014.10.013.
    [34]
    NATH B, SZABO G. Hypoxia and hypoxia inducible factors: diverse roles in liver diseases[J]. Hepatology, 2012, 55(2): 622-633. DOI: 10.1002/hep.25497.
    [35]
    WANG X, de CARVALHO RIBEIRO M, IRACHETA-VELLVE A, et al. Macrophage-specific hypoxia-inducible factor-1α contributes to impaired autophagic flux in nonalcoholic steatohepatitis[J]. Hepatology, 2019, 69(2): 545-563. DOI: 10.1002/hep.30215.
    [36]
    ZHANG X, HUANG C, LI X, et al. HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling[J]. BMC Gastroenterol, 2020, 20(1): 366. DOI: 10.1186/s12876-020-01515-5.
    [37]
    DENG J, HUANG Q, WANG Y, et al. Hypoxia-inducible factor-1alpha regulates autophagy to activate hepatic stellate cells[J]. Biochem Biophys Res Commun, 2014, 454(2): 328-334. DOI: 10.1016/j.bbrc.2014.10.076.
    [38]
    JIN Y, BAI Y, NI H, et al. Activation of autophagy through calcium-dependent AMPK/mTOR and PKCθ pathway causes activation of rat hepatic stellate cells under hypoxic stress[J]. FEBS Lett, 2016, 590(5): 672-682. DOI: 10.1002/1873-3468.12090.
    [39]
    MUELLER S. Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis[J]. World J Gastroenterol, 2016, 22(48): 10482-10501. DOI: 10.3748/wjg.v22.i48.10482.
    [40]
    BAFFY G. Origins of portal hypertension in nonalcoholic fatty liver disease[J]. Dig Dis Sci, 2018, 63(3): 563-576. DOI: 10.1007/s10620-017-4903-5.
    [41]
    DUPONT N, CODOGNO P. Autophagy transduces physical constraints into biological responses[J]. Int J Biochem Cell Biol, 2016, 79: 419-426. DOI: 10.1016/j.biocel.2016.08.021.
    [42]
    CLAUDE-TAUPIN A, CODOGNO P, DUPONT N. Links between autophagy and tissue mechanics[J]. J Cell Sci, 2021, 134(17): jcs258589. DOI: 10.1242/jcs.258589.
    [43]
    YANG J, LIANG J, ZHENG Y, et al. Hepatic polarization accelerated by mechanical compaction involves HNF4 activation[J]. Biomed Res Int, 2020, 2020: 8016306. DOI: 10.1155/2020/8016306.
    [44]
    LEE DH, PARK SH, AHN J, et al. Mir214-3p and Hnf4a/Hnf4α reciprocally regulate Ulk1 expression and autophagy in nonalcoholic hepatic steatosis[J]. Autophagy, 2021, 17(9): 2415-2431. DOI: 10.1080/15548627.2020.1827779.
    [45]
    SERA T, SUMII T, FUJITA R, et al. Effect of shear stress on the migration of hepatic stellate cells[J]. In Vitro Cell Dev Biol Anim, 2018, 54(1): 11-22. DOI: 10.1007/s11626-017-0202-x.
    [46]
    SAKATA R, UENO T, NAKAMURA T, et al. Mechanical stretch induces TGF-beta synthesis in hepatic stellate cells[J]. Eur J Clin Invest, 2004, 34(2): 129-136. DOI: 10.1111/j.1365-2362.2004.01302.x.
    [47]
    CASTAGNARO S, CHRISAM M, CESCON M, et al. Extracellular collagen VI has prosurvival and autophagy instructive properties in mouse fibroblasts[J]. Front Physiol, 2018, 9: 1129. DOI: 10.3389/fphys.2018.01129.
    [48]
    TOTARO A, ZHUANG Q, PANCIERA T, et al. Cell phenotypic plasticity requires autophagic flux driven by YAP/TAZ mechanotransduction[J]. Proc Natl Acad Sci U S A, 2019, 116(36): 17848-17857. DOI: 10.1073/pnas.1908228116.
    [49]
    LEE YA, NOON LA, AKAT KM, et al. Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap[J]. Nat Commun, 2018, 9(1): 4962. DOI: 10.1038/s41467-018-07338-z.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (449) PDF downloads(33) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return